Celcuity

NAQ:CELC · US15102K1007

BiotechnologySmall

360° View

Value96

Price/Sales65

Price/Earnings93

Price/Book100

Dividend Yield—

Growth97

Revenue Growth—

Profit Growth19

Capital Growth82

TSR 52w100

Safety64

Leverage6

Liquidity79

Refinancing81

Combined100

Sentiment71

Analyst Opinions74

Pro Holdings61

Opinion Changes26

Market Pulse79

Profile

CountryUSA

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeNASDAQCM

Founded2011

Employees166

Websitecelcuity.com

ISINUS15102K1007

Last UpdateApr 2, 2026

Index & Theme

UrologyHealth DiagnosticsOncologyBiotechnologyTherapeutics

Description

Celcuity Inc. operates as a clinical-stage biotechnology company. The company focuses on the development of targeted therapies for the treatment of multiple solid tumor indications. The company’s lead therapeutic candidate is gedatolisib, a kinase i…

Analysis

Celcuity's 360° View rank of 96 places it among the strongest overall — better than 96% of its true peers.

It's a growth standout (97) and looks cheap versus peers (96). On safety it is financially sound (64), and the market shows favorable sentiment (71). Taken together, its Combined rank of 100 reads as among the strongest overall.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

100

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Celcuity with its peers

Oncolytics Biotech

NAQ:ONCY

—

CountryCanada

IndustryBiotechnology

SizeX-Small

Full Stock Analysis →

Olema Pharmaceuticals

NSQ:OLMA

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Acrivon Therapeutics

NMQ:ACRV

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Crescent Biopharma

NAQ:CBIO

CountryUSA

IndustryBiotechnology

SizeX-Small

Full Stock Analysis →

Vir Biotechnology

NSQ:VIR

CountryUSA

IndustryBiotechnology

SizeMedium

Full Stock Analysis →

Sellas Life Sciences

NAQ:SLS

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →